ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Aclaris Therapeutics, Inc. - Common Stock (NQ:ACRS)

4.315 -0.235 (-5.16%)

Streaming Delayed Price Updated: 12:14 PM EDT, Apr 24, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	533,844
Open	4.362
Bid (Size)	4.310 (1,200)
Ask (Size)	4.320 (1,200)
Prev. Close	4.550
Today's Range	4.310 - 4.540
52wk Range	1.120 - 4.890
Shares Outstanding	107,850,124
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround ↗

February 03, 2026

CarMax runs a nationwide network of used car stores and digital channels, offering multi-channel sales and financing to U.S. consumers.

Via The Motley Fool

Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter. ↗

February 03, 2026

This clinical-stage biotech develops therapies targeting autoimmune and neuroinflammatory diseases with a focus on TYK2 inhibition.

Via The Motley Fool

Performance

YTD	+49.8%	+49.8%
1 Month	+30.8%	+30.8%
3 Month	-4.7%	-4.7%
6 Month	+90.9%	+90.9%
1 Year	+262.6%	+262.6%

More News

Here are the top movers in Tuesday's session. ↗

January 20, 2026

Via Chartmill

Tuesday's session: top gainers and losers ↗

January 20, 2026

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

January 20, 2026

Via Chartmill

Stock Market Today: US Future Edge Higher Ahead Of FOMC Decision—Meta, Microsoft Earnings In Focus ↗

July 30, 2025

Via Benzinga

Aclaris Therapeutics Stock Spikes In After‑Hours Session Following Major Announcement ↗

July 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 29, 2025

Via Benzinga

What's going on in today's after hours session ↗

July 29, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 28, 2025

Via Benzinga

This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

May 28, 2025

Via Benzinga

Aclaris Stock Rises As Analyst Projects Billions In Sales For New Therapy ↗

December 23, 2024

Via Benzinga

Santa Rally, January Effect, And Top Stock Picks ↗

December 23, 2024

Via Talk Markets

This Weyerhaeuser Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday ↗

December 23, 2024

Via Benzinga

Level Up Your Trading: Inside The 4-Pillar Strategy Behind Triple-Digit Returns ↗

December 18, 2024

Via Talk Markets

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 19, 2024

Via Benzinga

Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments ↗

November 19, 2024

Via Benzinga

War, Gold, And Opportunity: Uncovering Today’s Market Moves ↗

November 19, 2024

Via Talk Markets

This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

November 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 28, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 25, 2024

Via Benzinga

Aclaris Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying ↗

July 23, 2024

Via Benzinga

3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices

July 11, 2024

Via MarketBeat

Aclaris Therapeutics And 1 Other Stock Under $5 Insiders Are Buying ↗

July 08, 2024

Via Benzinga

$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying ↗

June 14, 2024

Via Benzinga

Frequently Asked Questions

Is Aclaris Therapeutics, Inc. - Common Stock publicly traded?

Yes, Aclaris Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Aclaris Therapeutics, Inc. - Common Stock trade on?

Aclaris Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Aclaris Therapeutics, Inc. - Common Stock?

The ticker symbol for Aclaris Therapeutics, Inc. - Common Stock is ACRS on the Nasdaq Stock Market

What is the current price of Aclaris Therapeutics, Inc. - Common Stock?

The current price of Aclaris Therapeutics, Inc. - Common Stock is 4.315

When was Aclaris Therapeutics, Inc. - Common Stock last traded?

The last trade of Aclaris Therapeutics, Inc. - Common Stock was at 04/24/26 12:14 PM ET

What is the market capitalization of Aclaris Therapeutics, Inc. - Common Stock?

The market capitalization of Aclaris Therapeutics, Inc. - Common Stock is 465.37M

How many shares of Aclaris Therapeutics, Inc. - Common Stock are outstanding?

Aclaris Therapeutics, Inc. - Common Stock has 465M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.